Ackerman, S., Hartmann, F., Pearson, C., Gonzalez, J., Ho, P. Y., Kimmey, S., Luo, A., Ackerman, B., Lee, A., Laura, R., Paik, J., Henning, K., Jackson, D., Chapin, S., Devens, B., Dornan, D., Bendall, S., Engleman, E., & Alonso, M. (n.d.). 603 Covalent attachment of a TLR7/8 agonist to tumor-targeting antibodies drives potent anti-tumor efficacy by synergistically activating FcgR- and TLR- signaling and enables safe systemic administration. Journal for immunotherapy of cancer, 8, A638. http://access.bl.uk/ark:/81055/vdc_100144731570.0x000002